Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.

Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L.

Neurology. 2019 Feb 8. pii: 10.1212/WNL.0000000000007032. doi: 10.1212/WNL.0000000000007032. [Epub ahead of print]

PMID:
30737333
2.

Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J.

Ann Clin Transl Neurol. 2018 Oct 16;5(12):1478-1491. doi: 10.1002/acn3.638. eCollection 2018 Dec.

3.

Learning ability correlates with brain atrophy and disability progression in RRMS.

Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15.

4.

Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.

Tomic D, Kemp WW, Roberts SK.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1103-1115. doi: 10.1097/MEG.0000000000001235. Review.

PMID:
30113367
5.

Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset.

Altermatt A, Gaetano L, Magon S, Häring DA, Tomic D, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Brain Topogr. 2018 Sep;31(5):886-894. doi: 10.1007/s10548-018-0652-9. Epub 2018 May 29.

PMID:
29845492
6.

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.

Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.

Neurology. 2018 Apr 10;90(15):e1324-e1332. doi: 10.1212/WNL.0000000000005292. Epub 2018 Mar 14.

PMID:
29540589
7.

Cost Analysis of the Addition of Hyperacute Magnetic Resonance Imaging for Selection of Patients for Endovascular Stroke Therapy.

John S, Thompson NR, Lesko T, Papesh N, Obuchowski N, Tomic D, Wisco D, Khawaja Z, Uchino K, Man S, Cheng-Ching E, Toth G, Masaryk T, Ruggieri P, Modic M, Hussain MS.

Interv Neurol. 2017 Oct;6(3-4):183-190. doi: 10.1159/000472158. Epub 2017 May 5.

8.

Dysphagia: Thinking outside the box.

Philpott H, Garg M, Tomic D, Balasubramanian S, Sweis R.

World J Gastroenterol. 2017 Oct 14;23(38):6942-6951. doi: 10.3748/wjg.v23.i38.6942. Review.

9.

α4-integrin receptor desaturation and disease activity return after natalizumab cessation.

Derfuss T, Kovarik JM, Kappos L, Savelieva M, Chhabra R, Thakur A, Zhang Y, Wiendl H, Tomic D.

Neurol Neuroimmunol Neuroinflamm. 2017 Aug 25;4(5):e388. doi: 10.1212/NXI.0000000000000388. eCollection 2017 Sep.

10.

"No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis.

Giovannoni G, Tomic D, Bright JR, Havrdová E.

Mult Scler. 2017 Aug;23(9):1179-1187. doi: 10.1177/1352458517703193. Epub 2017 Apr 6. Review.

11.

Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.

Giovannoni G, Cutter G, Sormani MP, Belachew S, Hyde R, Koendgen H, Knappertz V, Tomic D, Leppert D, Herndon R, Wheeler-Kingshott CAM, Ciccarelli O, Selwood D, di Cantogno EV, Ben-Amor AF, Matthews P, Carassiti D, Baker D, Schmierer K.

Mult Scler Relat Disord. 2017 Feb;12:70-78. doi: 10.1016/j.msard.2017.01.007. Epub 2017 Jan 17. Review.

PMID:
28283111
12.

Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.

Merschhemke M, Tomic D, Putzki N.

JAMA Neurol. 2016 Nov 1;73(11):1375. doi: 10.1001/jamaneurol.2016.3199. No abstract available.

PMID:
27669336
13.

"It's Always the Judge's Fault": Attention, Emotion Recognition, and Expertise in Rhythmic Gymnastics Assessment.

van Bokhorst LG, Knapová L, Majoranc K, Szebeni ZK, Táborský A, Tomić D, Cañadas E.

Front Psychol. 2016 Jul 5;7:1008. doi: 10.3389/fpsyg.2016.01008. eCollection 2016.

14.

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.

Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N.

Mult Scler. 2017 Apr;23(5):656-664. doi: 10.1177/1352458516659550. Epub 2016 Jul 18.

PMID:
27411701
15.

Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.

De Stefano N, Tomic D, Radue EW, Sprenger T, Meier DP, Häring D, Sormani MP.

Mult Scler Relat Disord. 2016 May;7:98-101. doi: 10.1016/j.msard.2016.03.017. Epub 2016 Mar 31.

PMID:
27237768
16.

Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.

Wang C, Beadnall HN, Hatton SN, Bader G, Tomic D, Silva DG, Barnett MH.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):754-7. doi: 10.1136/jnnp-2015-312304. Epub 2016 Apr 12.

17.

Comparison of high glucose concentration blood and crystalloid cardioplegia in paediatric cardiac surgery: a randomized clinical trial.

Mimic B, Ilic S, Vulicevic I, Milovanovic V, Tomic D, Mimic A, Stankovic S, Zecevic T, Davies B, Djordjevic M.

Interact Cardiovasc Thorac Surg. 2016 May;22(5):553-60. doi: 10.1093/icvts/ivv391. Epub 2016 Jan 31.

18.

Optimizing treatment success in multiple sclerosis.

Ziemssen T, Derfuss T, de Stefano N, Giovannoni G, Palavra F, Tomic D, Vollmer T, Schippling S.

J Neurol. 2016 Jun;263(6):1053-65. doi: 10.1007/s00415-015-7986-y. Epub 2015 Dec 24. Review.

19.

Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.

Kappos L, Radue EW, Chin P, Ritter S, Tomic D, Lublin F.

J Neurol. 2016 Feb;263(2):354-360. doi: 10.1007/s00415-015-7978-y. Epub 2015 Dec 8.

20.

Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.

Kappos L, De Stefano N, Freedman MS, Cree BA, Radue EW, Sprenger T, Sormani MP, Smith T, Häring DA, Piani Meier D, Tomic D.

Mult Scler. 2016 Sep;22(10):1297-305. doi: 10.1177/1352458515616701. Epub 2015 Nov 19.

21.

Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.

Derfuss T, Bergvall NK, Sfikas N, Tomic DL.

Curr Med Res Opin. 2015;31(9):1687-91. doi: 10.1185/03007995.2015.1067191. Epub 2015 Aug 20.

PMID:
26121423
22.

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.

Cohen JA, Khatri B, Barkhof F, Comi G, Hartung HP, Montalban X, Pelletier J, Stites T, Ritter S, von Rosenstiel P, Tomic D, Kappos L; TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):468-75. doi: 10.1136/jnnp-2015-310597. Epub 2015 Jun 25.

23.

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

Kappos L, Radue EW, Comi G, Montalban X, Butzkueven H, Wiendl H, Giovannoni G, Hartung HP, Derfuss T, Naegelin Y, Sprenger T, Mueller-Lenke N, Griffiths S, von Rosenstiel P, Gottschalk R, Zhang Y, Dahlke F, Tomic D; TOFINGO study group.

Neurology. 2015 Jul 7;85(1):29-39. doi: 10.1212/WNL.0000000000001706. Epub 2015 May 29.

24.

No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.

Nixon R, Bergvall N, Tomic D, Sfikas N, Cutter G, Giovannoni G.

Adv Ther. 2014 Nov;31(11):1134-54. doi: 10.1007/s12325-014-0167-z. Epub 2014 Nov 21.

25.

Nutrition labelling of pre-packaged foods in Belgrade, Serbia: current situation.

Davidović DB, Tomić DV, Paunović KŽ, Vasiljević ND, Jorga JB.

Public Health Nutr. 2015 Aug;18(11):1969-78. doi: 10.1017/S1368980014002353. Epub 2014 Nov 6.

PMID:
25374093
26.

Relapses in patients treated with fingolimod after previous exposure to natalizumab.

Comi G, Gold R, Dahlke F, Sinha A, von Rosenstiel P, Tomic D, Kappos L.

Mult Scler. 2015 May;21(6):786-90. doi: 10.1177/1352458514549404. Epub 2014 Sep 25.

PMID:
25257618
27.

Lorenz Heister's handbook of surgery in the Franciscan monastery in Pazin.

Tomić D, Laginja S.

Med Glas (Zenica). 2014 Feb;11(1):228-33.

PMID:
24496369
28.

European validation of a real-time PCR-based method for detection of Listeria monocytogenes in soft cheese.

Gianfranceschi MV, Rodriguez-Lazaro D, Hernandez M, González-García P, Comin D, Gattuso A, Delibato E, Sonnessa M, Pasquali F, Prencipe V, Sreter-Lancz Z, Saiz-Abajo MJ, Pérez-De-Juan J, Butrón J, Kozačinski L, Tomic DH, Zdolec N, Johannessen GS, Jakočiūnė D, Olsen JE, De Santis P, Lovari S, Bertasi B, Pavoni E, Paiusco A, De Cesare A, Manfreda G, De Medici D.

Int J Food Microbiol. 2014 Aug 1;184:128-33. doi: 10.1016/j.ijfoodmicro.2013.12.021. Epub 2013 Dec 28.

PMID:
24468028
29.

[Can decubitus ulcer be fatal? - case report].

Tomić D, Laginja S.

Acta Med Croatica. 2013 Oct;67 Suppl 1:107-9. Croatian.

PMID:
24371984
30.

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L; FIRST Study Investigators.

J Neurol. 2014 Feb;261(2):267-76. doi: 10.1007/s00415-013-7115-8. Epub 2013 Nov 13.

31.

Endoscopic ultrasound for differential diagnosis of duodenal lesions.

Pavlovic Markovic A, Rösch T, Alempijevic T, Krstic M, Tomic D, Dugalic P, Sokic Milutinovic A, Bulajic M.

Ultraschall Med. 2012 Dec;33(7):E210-E217. doi: 10.1055/s-0032-1313135. Epub 2012 Nov 5.

PMID:
23129520
32.

Assessment of metabolic syndrome in patients with primary biliary cirrhosis.

Alempijevic T, Sokic-Milutinovic A, Pavlovic Markovic A, Jesic-Vukicevic R, Milicic B, Macut D, Popovic D, Tomic D.

Wien Klin Wochenschr. 2012 Apr;124(7-8):251-5. doi: 10.1007/s00508-012-0162-9. Epub 2012 Apr 25.

PMID:
22531844
33.

Frequency and clinical caracteristics of colorectal adenoma and carcinoma in women.

Alempijević T, Milutinović AS, Marković AP, Krstić R, Popović D, Djuranović S, Spuran M, Tomić D, Ugljesić M.

Acta Chir Iugosl. 2011;58(4):51-4.

PMID:
22519192
34.

Dietary habits as a risk factor of gallstone disease in Serbia.

Davidović DB, Tomić DV, Jorg JB.

Acta Chir Iugosl. 2011;58(4):41-4.

PMID:
22519190
35.

Ultrasound diagnosis of gallbladder polyps.

Tomić DV, Marković AR, Alempijević TM, Davidović DB, Prsić DR, Vucković MS.

Acta Chir Iugosl. 2011;58(4):31-5.

PMID:
22519188
36.

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.

Brooks DJ, Papapetropoulos S, Vandenhende F, Tomic D, He P, Coppell A, O'Neill G.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):55-60. doi: 10.1097/WNF.0b013e3181d137d2.

PMID:
20375654
37.

Acquisition of /s/ clusters in Croatian speaking children with phonological disorders.

Mildner V, Tomić D.

Clin Linguist Phon. 2010 Jan;24(3):224-38. doi: 10.3109/02699200903362893.

PMID:
20144082
38.

Photobleaching for optical waveguide formation in a guest-host polyimide.

Tomić D, Mickelson A.

Appl Opt. 1999 Jun 20;38(18):3893-903.

PMID:
18319996
39.

[Ultrasonographic aspects of liver segmentation].

Alempijević T, Kovacević N, Stimec B, Tomić D.

Med Pregl. 2007 Sep-Oct;60(9-10):501-4. Review. Serbian.

PMID:
18265601
40.

Gastric multicentric glomangioma: a case report of this rare cause of abdominal pain.

Alempijevic T, Knezevic S, Knezevic D, Ostojic S, Stojakov D, Micev M, Tomic D, Krstic M.

Med Sci Monit. 2008 Jan;14(1):CS5-8.

PMID:
18160947
41.

Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension.

Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M.

World J Gastroenterol. 2007 Oct 28;13(40):5331-5.

42.

[Fever of unknown origin--a case report of brucellar discitis].

Tomić D, Stokić E, Turkulov V, Ivković-Lazar T.

Med Pregl. 2007 Jan-Feb;60(1-2):77-9. Serbian.

PMID:
17853716
43.

[Noninvasive assessment of oesophageal varices presence and size in patients with liver cirrhosis using right liver lobe/serum albumin concentration].

Alempijević T, Bulat V, Kovacević N, Jegić R, Duranović S, Tomić D, Krstić M.

Vojnosanit Pregl. 2007 Jul;64(7):453-7. Serbian.

PMID:
17821919
44.

Double common bile duct: a case report.

Djuranovic SP, Ugljesic MB, Mijalkovic NS, Korneti VA, Kovacevic NV, Alempijevic TM, Radulovic SV, Tomic DV, Spuran MM.

World J Gastroenterol. 2007 Jul 21;13(27):3770-2.

45.

Snodgrass' urethroplasty in hypospadias surgery in Clinical Hospital Mostar--preliminary report.

Brekalo Z, Kvesić A, Nikolić H, Tomić D, Martinović V.

Coll Antropol. 2007 Mar;31(1):189-93.

PMID:
17598400
46.

The aryl hydrocarbon receptor is required for normal gonadotropin responsiveness in the mouse ovary.

Barnett KR, Tomic D, Gupta RK, Babus JK, Roby KF, Terranova PF, Flaws JA.

Toxicol Appl Pharmacol. 2007 Aug 15;223(1):66-72. Epub 2007 May 26.

47.

Correlates of sexual functioning among mid-life women.

Gallicchio L, Schilling C, Tomic D, Miller SR, Zacur H, Flaws JA.

Climacteric. 2007 Apr;10(2):132-42.

PMID:
17453861
48.

Forebrain connectivity of the prefrontal cortex in the marmoset monkey (Callithrix jacchus): an anterograde and retrograde tract-tracing study.

Roberts AC, Tomic DL, Parkinson CH, Roeling TA, Cutter DJ, Robbins TW, Everitt BJ.

J Comp Neurol. 2007 May 1;502(1):86-112.

PMID:
17335041
49.

The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness.

Barnett KR, Tomic D, Gupta RK, Miller KP, Meachum S, Paulose T, Flaws JA.

Biol Reprod. 2007 Jun;76(6):1062-70. Epub 2007 Feb 28.

PMID:
17329597
50.

[Significance of color Doppler ultrasonography in the assessment of pancreatic carcinoma vascular invasion].

Alempijević T, Kovacević N, Tomić D, Duranović S, Krstić M.

Vojnosanit Pregl. 2006 Oct;63(10):857-60. Serbian.

PMID:
17121376

Supplemental Content

Support Center